Kappa Pharmaceuticals Limited – Trademark Portfolio

Entity Type: 03

Kappa Pharmaceuticals Limited holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include LESSON, LESS ON, and BANNAKOLD. The owner is based in Reading RG8 0EN.

Alexander House, Gatehampton Road

Goring on Thames

Reading RG8 0EN , GB

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LESS ON
LESS ON
Registered 2003
LESSON
LESSON
Registered 1999
BANNAKOLD
BANNAKOLD
Registered 1998
KAPPA
KAPPA
Abandoned 1995

Trademark Classifications

Kappa Pharmaceuticals Limited's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Kappa Pharmaceuticals Limited have?

Kappa Pharmaceuticals Limited has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.

What trademark classes does Kappa Pharmaceuticals Limited file in?

Kappa Pharmaceuticals Limited files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Kappa Pharmaceuticals Limited's most well-known trademarks?

Kappa Pharmaceuticals Limited's registered trademark portfolio includes well-known marks such as LESSON, LESS ON, and BANNAKOLD. These are among 3 currently registered trademarks in the portfolio.

What is Kappa Pharmaceuticals Limited's trademark registration success rate?

Kappa Pharmaceuticals Limited has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.